Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With

Stuart C Gordon1,2, Eyasu H Teshale3, Philip R Spradling3

  • 1Department of Gastroenterology and Hepatology, Henry Ford Health System, Detroit Michigan, USA.

Insights

Patients with hepatitis C virus (HCV) achieving sustained virological response after direct-acting antiviral therapy had fewer emergency department visits and hospitalizations. This demonstrates the significant health benefits of successful HCV treatment.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection poses a significant global health burden.
  • Direct-acting antiviral (DAA) therapies have revolutionized HCV treatment, leading to high rates of sustained virological response (SVR).
  • Understanding the long-term impact of SVR on healthcare utilization is crucial for resource planning and patient management.

Purpose of the Study:

  • To compare the rates of emergency department (ED) visits and hospitalizations between HCV patients who achieved SVR after DAA therapy and matched controls.
  • To assess the impact of successful HCV treatment on liver-related and all-cause healthcare utilization.

Main Methods:

  • A retrospective cohort study design was employed.
  • 3049 pairs of patients achieving SVR after DAA therapy (case patients) and matched controls were analyzed.
  • Rates of liver-related ED visits, all-cause hospitalizations, liver-related hospitalizations, and hospitalized days were compared between groups.

Main Results:

  • Case patients showed significantly lower rates of liver-related ED visits compared to controls (P = .01).
  • All-cause hospitalization rates, liver-related hospitalization rates, and the number of hospitalized days were significantly lower in case patients (P < .001).

Conclusions:

  • Achieving sustained virological response after direct-acting antiviral therapy for hepatitis C virus is associated with reduced healthcare utilization.
  • Successful HCV treatment leads to decreased emergency department visits and hospitalizations, highlighting the clinical and economic benefits of DAA therapy.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
6
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
10
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
6
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
258
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K